Sun Pharmaceutical Industries generates massive multi-billion-dollar annual revenues on a global scale, with trailing twelve-month revenues scaling at approximately ₹56,630 crores to ₹61,029 crores (or roughly $6.8 billion to $7.3 billion USD). A substantial portion of this total turnover is derived from international exports to the United States and emerging markets, alongside a formidable domestic market share within India.